Insight Molecular Diagnostics Inc. (IMDX) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $5.67
• Market Cap: $164.93M
• EPS: $-3.21
• 52-Week High: $8.51
• 52-Week Low: $2.33

Market Sentiment

Insight Molecular Diagnostics Inc. currently has a Bullish sentiment score of 0.43.

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. (IMDX) is a leading precision diagnostics company headquartered in Irvine, California, focused on transforming the landscape of molecular testing to improve patient care. The company specializes in developing cutting-edge diagnostic solutions that target critical unmet needs in oncology, leveraging innovative technologies to provide accurate and timely testing results. With a strong commitment to enhancing disease detection and patient outcomes, IMDX is stra...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Insight Molecular Diagnostics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMDX pay dividends?

Insight Molecular Diagnostics Inc. (IMDX) does not currently pay a regular dividend.

What is IMDX's market cap?

Insight Molecular Diagnostics Inc. (IMDX) has a market capitalization of $164.93M with a current stock price of $5.67.